Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 01:06:02 UTC |
---|
Update Date | 2022-11-23 21:42:16 UTC |
---|
HMDB ID | HMDB0247946 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Aclacinomycin N |
---|
Description | methyl 4-{[4-(dimethylamino)-5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate belongs to the class of organic compounds known as dihydropyridinecarboxylic acids and derivatives. Dihydropyridinecarboxylic acids and derivatives are compounds containing a dihydropyridine moiety bearing a carboxylic acid group. Based on a literature review very few articles have been published on methyl 4-{[4-(dimethylamino)-5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate. This compound has been identified in human blood as reported by (PMID: 31557052 ). Aclacinomycin n is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Aclacinomycin N is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCC1(O)CC(OC2CC(C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)N(C)C)C2=C(O)C3=C(C=C2C1C(=O)OC)C(=O)C1=CC=CC(O)=C1C3=O InChI=1S/C42H55NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24-25,27-31,35,39-40,44-46,49,51H,8,12-13,15-17H2,1-7H3 |
---|
Synonyms | Value | Source |
---|
Methyl 4-{[4-(dimethylamino)-5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid | Generator |
|
---|
Chemical Formula | C42H55NO15 |
---|
Average Molecular Weight | 813.894 |
---|
Monoisotopic Molecular Weight | 813.357170075 |
---|
IUPAC Name | methyl 4-{[4-(dimethylamino)-5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate |
---|
Traditional Name | methyl 4-{[4-(dimethylamino)-5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC1(O)CC(OC2CC(C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)N(C)C)C2=C(O)C3=C(C=C2C1C(=O)OC)C(=O)C1=CC=CC(O)=C1C3=O |
---|
InChI Identifier | InChI=1S/C42H55NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24-25,27-31,35,39-40,44-46,49,51H,8,12-13,15-17H2,1-7H3 |
---|
InChI Key | CPUWOKRFRYWIHK-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dihydropyridinecarboxylic acids and derivatives. Dihydropyridinecarboxylic acids and derivatives are compounds containing a dihydropyridine moiety bearing a carboxylic acid group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Hydropyridines |
---|
Direct Parent | Dihydropyridinecarboxylic acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Dihydropyridinecarboxylic acid derivative
- Nitrobenzene
- Nitroaromatic compound
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Benzenoid
- Methyl ester
- Enoate ester
- Alpha,beta-unsaturated carboxylic ester
- Vinylogous amide
- Organic nitro compound
- Carboxylic acid ester
- C-nitro compound
- Amino acid or derivatives
- Azacycle
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Carboxylic acid derivative
- Allyl-type 1,3-dipolar organic compound
- Secondary aliphatic amine
- Enamine
- Organic oxoazanium
- Secondary amine
- Organopnictogen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
aclacinomycin N,1TMS,isomer #1 | CCC1(O[Si](C)(C)C)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 5724.1 | Semi standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #1 | CCC1(O[Si](C)(C)C)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 5569.8 | Standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #1 | CCC1(O[Si](C)(C)C)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 7819.3 | Standard polar | 33892256 | aclacinomycin N,1TMS,isomer #2 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O[Si](C)(C)C)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 5737.7 | Semi standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #2 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O[Si](C)(C)C)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 5505.4 | Standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #2 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O[Si](C)(C)C)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 7665.8 | Standard polar | 33892256 | aclacinomycin N,1TMS,isomer #3 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O[Si](C)(C)C)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 5740.5 | Semi standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #3 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O[Si](C)(C)C)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 5612.2 | Standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #3 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O[Si](C)(C)C)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O)C1C(=O)OC | 7698.0 | Standard polar | 33892256 | aclacinomycin N,1TMS,isomer #4 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O[Si](C)(C)C)C1C(=O)OC | 5730.2 | Semi standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #4 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O[Si](C)(C)C)C1C(=O)OC | 5577.2 | Standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #4 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O)=C4C(=O)C3=C2O[Si](C)(C)C)C1C(=O)OC | 7755.6 | Standard polar | 33892256 | aclacinomycin N,1TMS,isomer #5 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O[Si](C)(C)C)=C4C(=O)C3=C2O)C1C(=O)OC | 5776.9 | Semi standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #5 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O[Si](C)(C)C)=C4C(=O)C3=C2O)C1C(=O)OC | 5593.4 | Standard non polar | 33892256 | aclacinomycin N,1TMS,isomer #5 | CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(O)C(C)O4)C(C)O3)C(C)O2)C2=C(C=C3C(=O)C4=CC=CC(O[Si](C)(C)C)=C4C(=O)C3=C2O)C1C(=O)OC | 7739.1 | Standard polar | 33892256 |
|
---|